$6.40
-$0.10
(-1.54%)
Quote as of 3:59 PM EST on 02/10/12
Protalix BioTherapeutics, Inc.
AMEX:PLX
|
$6.40
-$0.10
(-1.54%)
|
|
| Today's Open | $6.43 |
|---|---|
| Previous Close | $6.50 |
| Daily Range | $6.38 - $6.52 |
| 52-Week Range | $4.06 - $9.84 |
| Market Cap | $547.99M |
| P/E Ratio | -15.12 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 80,395 |
| Average Daily Volume | 175,750 |
| Current FY EPS | -$0.42 |
PLX Information
| Description |
|---|
| A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
3 Stocks to Get on Your Watchlist
Company News for December 7, 2011 - Corporate Summary
Protalix BioTherapeutics Shares Got Crushed: What You Need to Know
Regeneron Wins FDA Approval for Eye Drug: 3 Companies Up For Approval
14 Small Caps With 2 or More Analyst Downgrades in March
5 Stocks Near Lows Seeing Significant Short Covering
Top 30 Most Undervalued, Underperforming Stocks
Niche Opportunity May Be Slipping From Protalix's Grasp
